Skip navigation
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIzhakian, Yehuda-
dc.date.accessioned2012-02-17T16:25:05Z-
dc.date.available2012-02-17T16:25:05Z-
dc.date.issued2012-02-17T16:25:05Z-
dc.identifier.urihttp://hdl.handle.net/2451/31464-
dc.description.abstractThis paper generalizes the mean–variance preferences to mean–variance–ambiguity preferences by relaxing the standard assumption that probabilities are known and assuming that probabilities are themselves random. It introduces a new measure of uncertainty, one that consolidates risk and ambiguity, which is employed for extending the CAPM from risk to uncertainty by incorporating ambiguity. This model makes the distinction between systematic ambiguity and idiosyncratic ambiguity and proves that the ambiguity premium is proportional to the systematic ambiguity. The merit of this model is twofold: first, it can be tested empirically; second, it can serve for measuring the performance of portfolios relative to their uncertainty.en
dc.language.isoen_USen
dc.rightsCopyright Yehuda Izhakian, 2012.en
dc.subjectShadow Theoryen
dc.subjectAmbiguityen
dc.subjectAmbiguity Measureen
dc.subjectUncertainty Measureen
dc.subjectAmbiguity premiumen
dc.subjectmean-varianceen
dc.subjectmean-uncertaintyen
dc.subjectCapital Market Line (CML)en
dc.subjectCapital Asset Pricing Model (CAPM)en
dc.titleCapital Asset Pricing Under Ambiguityen
dc.typeWorking Paperen
dc.authorid-ssrn105813en
Appears in Collections:Economics Working Papers

Files in This Item:
File Description SizeFormat 
Izhakian-CapitalAssetPricing_Feb2012.pdfCapital Asset Pricing under Ambiguity236.31 kBAdobe PDFView/Open


Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.